In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat

Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain.

P. Ferrero, Mariarita Santi, Bianca M. Conti‐Tronconi et al. · Proceedings of the National Academy of Sciences · 1986 · 218 citations · Full text

Medicine, Neuroscience, Pharmacology +15

The octadecaneuropeptide [diazepam-binding inhibitor (33–50)] exerts potent anorexigenic effects in rodents

Juana Garcia de Mateos–Verchere, Jérôme Leprince, Marie‐Christine Tonon et al. · European Journal of Pharmacology · 2001 · 77 citations

Medicine, Medicinal Chemistry, Pharmacology +6

Structure−Activity Relationships of a Series of Analogues of the Octadecaneuropeptide ODN on Calcium Mobilization in Rat Astrocytes

Jérôme Leprince, Pierrick Gandolfo, Jean‐Louis Thoumas et al. · Journal of Medicinal Chemistry · 1998 · 71 citations

Life Sciences, Neuroscience, Pharmacology +17

Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN

Jérôme Leprince, Hassan Oulyadi, David Vaudry et al. · European Journal of Biochemistry · 2001 · 63 citations

Medicine, Neuroscience, Pharmacology +14

The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors

Pierrick Gandolfo, Christine Patte‐Mensah, Jérôme Leprince et al. · European Journal of Pharmacology · 1997 · 49 citations

Life Sciences, Neurobiology, Neuroscience +15